BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33861015)

  • 1. Primary cutaneous T-cell lymphomas in childhood and adolescence.
    Wohlmuth-Wieser I
    J Dtsch Dermatol Ges; 2021 Apr; 19(4):563-581. PubMed ID: 33861015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Cutaneous Lymphomas in Children and Adolescents.
    Ceppi F; Pope E; Ngan B; Abla O
    Pediatr Blood Cancer; 2016 Nov; 63(11):1886-94. PubMed ID: 27229270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nodal Involvement by CD30
    Lezama LS; Gratzinger D
    Arch Pathol Lab Med; 2018 Jan; 142(1):139-142. PubMed ID: 29257929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part II: Prognosis and management.
    Oh Y; Stoll JR; Moskowitz A; Pulitzer M; Horwitz S; Myskowski P; Noor SJ
    J Am Acad Dermatol; 2021 Nov; 85(5):1093-1106. PubMed ID: 33945836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous lymphoma: Kids are not just little people.
    Ferenczi K; Makkar HS
    Clin Dermatol; 2016; 34(6):749-759. PubMed ID: 27968935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous Lymphomas - Part I: Mycosis Fungoides, Sézary Syndrome, and CD30
    Pujol RM; Gallardo F
    Actas Dermosifiliogr (Engl Ed); 2021 Jan; 112(1):14-23. PubMed ID: 32896500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cutaneous T-cell lymphoma: a review of the most common entities with focus on recent updates.
    Saleh JS; Subtil A; Hristov AC
    Hum Pathol; 2023 Oct; 140():75-100. PubMed ID: 37802757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epitheliotropic lymphomas: better identification for improved treatment].
    Bagot M
    Bull Acad Natl Med; 2010 Oct; 194(7):1365-72. PubMed ID: 22043631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosis.
    Stoll JR; Willner J; Oh Y; Pulitzer M; Moskowitz A; Horwitz S; Myskowski P; Noor SJ
    J Am Acad Dermatol; 2021 Nov; 85(5):1073-1090. PubMed ID: 33940098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cutaneous lymphomas : Clinical presentation - diagnosis - treatment].
    Wobser M; Goebeler M
    Pathologe; 2020 Feb; 41(1):79-94. PubMed ID: 31932947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cutaneous lymphomas : Clinical presentation - diagnosis - treatment].
    Wobser M; Goebeler M
    Hautarzt; 2019 Oct; 70(10):815-830. PubMed ID: 31511903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD30-Positive Lymphoproliferative Disorders.
    Nikolaenko L; Zain J; Rosen ST; Querfeld C
    Cancer Treat Res; 2019; 176():249-268. PubMed ID: 30596222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin.
    DeCoteau JF; Butmarc JR; Kinney MC; Kadin ME
    Blood; 1996 Apr; 87(8):3437-41. PubMed ID: 8605362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Willemze R; Hodak E; Zinzani PL; Specht L; Ladetto M;
    Ann Oncol; 2013 Oct; 24 Suppl 6():vi149-54. PubMed ID: 23868906
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment.
    Bekkenk MW; Geelen FA; van Voorst Vader PC; Heule F; Geerts ML; van Vloten WA; Meijer CJ; Willemze R
    Blood; 2000 Jun; 95(12):3653-61. PubMed ID: 10845893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Practice Guidelines for Cutaneous Lymphomas.
    Sutton AM; Hurley MY
    Mo Med; 2015; 112(4):292-5. PubMed ID: 26455060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous CD30(+) lymphoproliferative disorders.
    Wieser I; Tetzlaff MT; Torres Cabala CA; Duvic M
    J Dtsch Dermatol Ges; 2016 Aug; 14(8):767-82. PubMed ID: 27509411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas.
    Whittaker SJ; Marsden JR; Spittle M; Russell Jones R; ;
    Br J Dermatol; 2003 Dec; 149(6):1095-1107. PubMed ID: 14696593
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary Cutaneous Lymphomas in Thailand: A 10-Year Retrospective Study.
    Pruksaeakanan C; Teyateeti P; Patthamalai P; Thumrongtharadol J; Chairatchaneeboon M
    Biomed Res Int; 2021; 2021():4057661. PubMed ID: 34235215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
    Paulli M; Berti E
    Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.